Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Martin SS, Qasim A, Reilly MP.

J Am Coll Cardiol. 2008 Oct 7;52(15):1201-10. doi: 10.1016/j.jacc.2008.05.060. Review.

2.
3.

Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.

Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM, Sattar N.

Atherosclerosis. 2007 Apr;191(2):418-26. Epub 2006 May 19.

PMID:
16712853
4.

Leptin and the cardiovascular system.

Rahmouni K, Haynes WG.

Recent Prog Horm Res. 2004;59:225-44. Review.

PMID:
14749504
5.

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men.

Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB.

Atherosclerosis. 2001 Aug;157(2):495-503.

PMID:
11472752
6.

Cardiovascular effects of leptin.

Sweeney G.

Nat Rev Cardiol. 2010 Jan;7(1):22-9. doi: 10.1038/nrcardio.2009.224. Epub 2009 Dec 1. Review.

PMID:
19949425
7.

Leptin, obesity and cardiovascular disease.

Correia ML, Haynes WG.

Curr Opin Nephrol Hypertens. 2004 Mar;13(2):215-23. Review.

PMID:
15202616
8.

Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.

Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D.

Curr Hypertens Rep. 2008 Apr;10(2):131-7. Review.

PMID:
18474180
9.

[Leptin--adipose tissue hormone and its role in cardiovascular diseases].

Racek-Król B.

Pol Merkur Lekarski. 2006 Jun;20(120):713-6. Review. Polish.

PMID:
17007277
10.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
11.

Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.

Sáinz N, Barrenetxe J, Moreno-Aliaga MJ, Martínez JA.

Metabolism. 2015 Jan;64(1):35-46. doi: 10.1016/j.metabol.2014.10.015. Epub 2014 Oct 23. Review.

PMID:
25497342
12.

Leptin signaling and obesity: cardiovascular consequences.

Yang R, Barouch LA.

Circ Res. 2007 Sep 14;101(6):545-59. Review.

13.

Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.

Kshatriya S, Reams GP, Spear RM, Freeman RH, Dietz JR, Villarreal D.

Curr Opin Nephrol Hypertens. 2010 Jan;19(1):72-8. doi: 10.1097/MNH.0b013e328332fb49. Review.

PMID:
19851106
14.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

PMID:
16613757
15.

Leptin and cardiovascular diseases.

Luo JD, Zhang GS, Chen MS.

Drug News Perspect. 2005 Sep;18(7):427-31. Review.

PMID:
16362081
17.

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.

Zimmet P, Boyko EJ, Collier GR, de Courten M.

Ann N Y Acad Sci. 1999 Nov 18;892:25-44. Review.

PMID:
10842650
18.

Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.

Correia ML, Rahmouni K.

Diabetes Obes Metab. 2006 Nov;8(6):603-10. Review.

PMID:
17026484
19.

Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.

Mark AL, Correia ML, Rahmouni K, Haynes WG.

J Hypertens. 2002 Jul;20(7):1245-50. Review.

PMID:
12131511
Items per page

Supplemental Content

Write to the Help Desk